Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T05:43:08.288Z Has data issue: false hasContentIssue false

Use of Multivitamins and Folic Acid in Early Pregnancy and Multiple Births in Sweden

Published online by Cambridge University Press:  21 February 2012

A. Ericson
Affiliation:
Epidemiological Centre, National Board of Health, Stockholm, Sweden.
B. Källén*
Affiliation:
Tornblad Institute, Lund, Sweden. embryol@embryol.lu.se.
A. Åberg
Affiliation:
Department of Obstetrics and Gynaecology, University Hospital, Lund, Sweden.
*
*Address for correspondence: Professor Bengt Källén, Tornblad Institute, Biskopsgatan 7, S-223 62 Lund, Sweden.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Folic acid is recommended to reduce the risk of neural tube defects and other congenital malformations. Data from the Swedish Medical Birth Registry were used to study frequency of twinning in women who in early pregnancy reported the use of folic acid. Women (n = 2,569) who in early pregnancy reported the use of folic acid had an increased rate of twin deliveries after consideration of maternal age and of length of involuntary childlessness, both variables being significant confounders. The effect of folic acid was seen also in women who did not report involuntary childlessness. A similar but not statistically significant trend was seen after use of multivitamins without simultaneous use of folic acid tablets (n = 1,979). The increased risk seems to be limited to dizygotic twinning (relative risk = 2.13, 95%CI 1.64–2.74). If this association is causal, wide-spread supplementation with folic acid may represent a hazard larger than the postulated beneficial effect on neural tube defects, at least in low-risk areas.

Type
Articles
Copyright
Copyright © Cambridge University Press 2001